Synthesize Bio
Synthesize Bio is an artificial intelligence company in Seattle, United States, founded in 2023. It has raised $10.0M across 1 round, most recently a $10.0M Seed in September 2025.
Virtual Human Modeling for Clinical Trials
- Headquarters
- Seattle, Washington
- Employees
- 11–50
- Founded
- 2023
- Business Model
- B2B
- Website
- synthesize.bio
- Total Funding
- $10.0M
- Last Round
- $10.0M SeedSep 2025
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 1 funding round for this company. The full record is or through the API.
About
Synthesize Bio develops generative genomics models for scientists studying the responses of human tissues and cells to drugs, diseases, and perturbations. By predicting those responses, the models expand what researchers can examine when investigating the biological effects of disease and therapeutic interventions.
Summary
It lists 11–50 employees. It has raised $10.0M in total across 1 round, most recently a $10.0M Seed round in Sep 2025.
Tech & App Stack
5 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sep 2025
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
Specialty pharmaceutical company
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/synthesize-bio"><img src="https://indexed.vc/api/badge/company/synthesize-bio" alt="Synthesize Bio on Indexed.vc" width="260" height="76" /></a>